Piramal Pharma Limited (PPLPHARMA.BO)
INR 260.3
(-1.68%)
INR 260.3
(-1.68%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 153.11 Billion INR | 5.43% |
| 2022 | 145.22 Billion INR | 13.48% |
| 2021 | 127.97 Billion INR | 122.3% |
| 2020 | 57.56 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 152.41 Billion INR | 0.0% |
| 2023 FY | 153.11 Billion INR | 5.43% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 147.75 Billion INR | 0.0% |
| 2023 Q4 | 153.11 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q2 | 136.7 Billion INR | 0.0% |
| 2022 FY | 145.22 Billion INR | 13.48% |
| 2022 Q4 | 145.22 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q4 | 127.97 Billion INR | 0.0% |
| 2021 FY | 127.97 Billion INR | 122.3% |
| 2020 FY | 57.56 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Ajanta Pharma Limited | 46.38 Billion INR | -230.11% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -4073.626% |
| Sigachi Industries Limited | 6.94 Billion INR | -2105.815% |
| Bal Pharma Limited | 3.2 Billion INR | -4679.131% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -1214.199% |
| Medico Remedies Limited | 961.95 Million INR | -15817.42% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -10049.097% |
| Venus Remedies Limited | 6.26 Billion INR | -2342.737% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -2872.936% |
| Alpa Laboratories Limited | 1.82 Billion INR | -8284.442% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -598.832% |
| Shilpa Medicare Limited | 30.93 Billion INR | -395.014% |
| Aarti Drugs Limited | 24.32 Billion INR | -529.504% |
| Lupin Limited | 239.97 Billion INR | 36.193% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 66.028% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 47.707% |
| Windlas Biotech Limited | 6.26 Billion INR | -2345.171% |
| Suven Life Sciences Limited | 2.84 Billion INR | -5274.4% |
| Eris Lifesciences Limited | 70.48 Billion INR | -117.225% |
| Valiant Laboratories Limited | 3.42 Billion INR | -4368.158% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | -283.358% |
| Solara Active Pharma Sciences Limited | 23.5 Billion INR | -551.3% |
| Ipca Laboratories Limited | 111.01 Billion INR | -37.928% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -1161.406% |
| Achyut Healthcare Limited | 309.52 Million INR | -49369.214% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 82.084% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -1901.21% |
| RPG Life Sciences Limited | 5.12 Billion INR | -2885.515% |
| Mankind Pharma Limited | 119.63 Billion INR | -27.99% |
| Laurus Labs Limited | 83.87 Billion INR | -82.565% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -3683.834% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | -1.665% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | -137.555% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | -6.638% |
| Unichem Laboratories Limited | 31.69 Billion INR | -383.122% |
| Sequent Scientific Limited | 15.4 Billion INR | -894.026% |
| Novartis India Limited | 9.24 Billion INR | -1555.456% |
| Wanbury Limited | 3.43 Billion INR | -4357.676% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -579.291% |
| Wockhardt Limited | 76.49 Billion INR | -100.181% |
| Themis Medicare Limited | 5.66 Billion INR | -2603.278% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -6953.598% |
| Jubilant Pharmova Limited | 115.48 Billion INR | -32.587% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | -437.179% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 60.487% |
| Divi's Laboratories Limited | 154.7 Billion INR | 1.023% |
| NATCO Pharma Limited | 69.06 Billion INR | -121.708% |
| Gufic Biosciences Limited | 10.92 Billion INR | -1301.485% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -582.223% |
| Ind-Swift Limited | 6.54 Billion INR | -2239.569% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -1827.566% |
| FDC Limited | 24.68 Billion INR | -520.391% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -8493.706% |
| Granules India Limited | 55.2 Billion INR | -177.339% |
| Medicamen Biotech Limited | 2.94 Billion INR | -5098.861% |
| Alkem Laboratories Limited | 155.74 Billion INR | 1.689% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -1320.353% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -32421.096% |
| Brooks Laboratories Limited | 904.45 Million INR | -16829.341% |
| Megasoft Limited | 3.65 Billion INR | -4084.701% |
| ZIM Laboratories Limited | 4.46 Billion INR | -3326.823% |
| Strides Pharma Science Limited | 58.39 Billion INR | -162.2% |
| Neuland Laboratories Limited | 18.32 Billion INR | -735.542% |
| Morepen Laboratories Limited | 12.93 Billion INR | -1084.02% |
| Hikal Limited | 24.87 Billion INR | -515.639% |
| Indoco Remedies Limited | 21.44 Billion INR | -613.927% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | -492.998% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -6278.284% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -4492.291% |
| Hester Biosciences Limited | 6.62 Billion INR | -2211.75% |